Skip to Content
Menu

Completed mesothelioma clinical trials have treated all study patients and finished collecting data. Once a study is completed, researchers examine the results. They will determine how and if to move forward with the treatment or technology at hand. Completed studies have improved mesothelioma survival.


01. Completed Clinical Trials

Completed Mesothelioma Clinical Trials

Clinical trials may help researchers better understand mesothelioma development and treatment. Clinical studies are considered completed once all treatments and follow-ups are done. This means researchers have collected the last data point from the last patient undergoing treatment. At this point, researchers examine the study results.

In the case of a clinical trial on mesothelioma treatment, this analysis helps answer many questions, including:

  • Was the treatment effective?
  • Did the benefits of the treatment outweigh the risks?
  • Does the treatment require further study?
  • Should the treatment be approved by the U.S. Food and Drug Administration (FDA)?

Once study coordinators have finished analyzing results, they may publish them in a medical journal. They may also share the study results in the trial’s ClinicalTrials.gov record.

For more information on clinical trials phases, processes, costs and enrollment, you can visit our Clinical Trials Overview page.

02. Clinical Trial Results

Mesothelioma Advances From Clinical Trials

Some completed clinical trials have tested treatments that substantially improved the prognosis for mesothelioma. Below are a few examples of noteworthy, completed mesothelioma clinical trials.

Immunotherapy for Inoperable Pleural Mesothelioma

Study Name: CheckMate-743

Study Purpose: To evaluate an immunotherapy combination treatment compared to standard chemotherapy (cisplatin and pemetrexed)

New Treatment: Opdivo® (nivolumab) and Yervoy® (ipilimumab)

Type of Mesothelioma: Inoperable pleural mesothelioma

Most Important Result: Improved survival. Patients treated with Opdivo® and Yervoy® had a median survival of 18.1 months. Those treated with standard chemotherapy had a median survival of 14.1 months.

FDA Approval Status: The FDA approved Opdivo® and Yervoy® for treatment of inoperable pleural mesothelioma in October 2020.

A New Treatment for Inoperable Pleural Mesothelioma

Study Name: STELLAR

Study Purpose: To determine the effect of a novel, electric field-based treatment for pleural mesothelioma

New Treatment: Novo-TTF-100L System

Type of Mesothelioma: Inoperable pleural mesothelioma

Most Important Result: Encouraging survival without increased systemic toxicity. Patients had standard chemotherapy treatment followed by Novo-TTF treatment. Median overall survival was 18.2 months, which compares favorably to other treatment options.

FDA Approval Status: The Novo-TTF-100L System gained FDA approval in 2019. It is approved for the treatment of inoperable pleural mesothelioma in combination with standard chemotherapy. Since the approval, the treatment has become more widely available to mesothelioma patients.

Improved Survival in Select Patients With Unresectable Pleural Mesothelioma

Study Name: MAPS (Mesothelioma Avastin® Plus Pemetrexed-cisplatin Study)

Study Purpose: To determine the effect of an immunotherapy drug on the survival of patients also undergoing standard chemotherapy treatment

New Treatment: Avastin® (bevacizumab)

Type of Mesothelioma: Inoperable pleural mesothelioma

Most Important Result: Improved survival. Patients treated with chemotherapy and Avastin® had a median survival of 18.8 months. Those treated with chemotherapy alone had a median survival of 16.1 months.

FDA Approval Status: The manufacturer did not submit an application for FDA approval. However, experts say Avastin® may be offered to patients who can tolerate it.

03. List of Completed Clinical Trials

Completed Mesothelioma Clinical Trials List

Provided below is a list of completed mesothelioma trials.

First-in-human Study of S-588210 (S-488210+S-488211)


Conditions: Mesothelioma

Last Updated: January 25, 2022

Status: Completed

Intravenous Magnesium in Patients Receiving Cisplatin


Conditions: Mesothelioma

Last Updated: January 10, 2022

Status: Completed

Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: December 29, 2021

Status: Completed

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies


Conditions: Mesothelioma

Last Updated: November 12, 2021

Status: Completed

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent


Conditions: Mesothelioma

Last Updated: November 10, 2021

Status: Completed

Vinorelbine in Mesothelioma


Conditions: Mesothelioma

Last Updated: October 4, 2021

Status: Completed

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 28, 2021

Status: Completed

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.


Conditions: Mesothelioma

Last Updated: July 13, 2021

Status: Completed

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)


Conditions: Mesothelioma

Last Updated: June 30, 2021

Status: Completed

Alvopem® (Pemetrexed) Safety Assessment


Conditions: Mesothelioma

Last Updated: April 10, 2021

Status: Completed

Olaparib in People With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: March 16, 2021

Status: Completed

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: March 16, 2021

Status: Completed

Diadem to Investigate the Activity and Safety of Durvalumab


Conditions: Mesothelioma

Last Updated: March 3, 2021

Status: Completed

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 20, 2021

Status: Completed

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin


Conditions: Mesothelioma

Last Updated: January 20, 2021

Status: Completed

Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 19, 2021

Status: Completed

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 8, 2021

Status: Completed

Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion


Conditions: Mesothelioma

Last Updated: December 2, 2020

Status: Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies


Conditions: Mesothelioma

Last Updated: October 28, 2020

Status: Completed

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)


Conditions: Mesothelioma

Last Updated: October 28, 2020

Status: Completed

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: September 30, 2020

Status: Completed

11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)


Conditions: Mesothelioma

Last Updated: September 29, 2020

Status: Completed

Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 23, 2020

Status: Completed

Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies


Conditions: Mesothelioma

Last Updated: September 20, 2020

Status: Completed

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer


Conditions: Mesothelioma

Last Updated: July 30, 2020

Status: Completed

Clinical and Histopathologic Characteristics of BAP1 Mutations


Conditions: Mesothelioma

Last Updated: June 30, 2020

Status: Completed

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: April 6, 2020

Status: Completed

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: March 31, 2020

Status: Completed

Gene Therapy for Pleural Malignancies


Conditions: Mesothelioma

Last Updated: March 16, 2020

Status: Completed

Combination Gene Transfer and Chemotherapy


Conditions: Mesothelioma

Last Updated: March 13, 2020

Status: Completed

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma

Last Updated: February 19, 2020

Status: Completed

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors


Conditions: Mesothelioma

Last Updated: February 13, 2020

Status: Completed

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)


Conditions: Mesothelioma

Last Updated: January 22, 2020

Status: Completed

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 8, 2019

Status: Completed

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma


Conditions: Mesothelioma

Last Updated: October 15, 2019

Status: Completed

Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers


Conditions: Mesothelioma

Last Updated: October 3, 2019

Status: Completed

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma


Conditions: Mesothelioma

Last Updated: September 19, 2019

Status: Completed

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: August 5, 2019

Status: Completed

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)


Conditions:

Last Updated: July 16, 2019

Status: Completed

Malignant Mesothelioma - Can we Improve Quality of Life


Conditions: Mesothelioma

Last Updated: June 12, 2019

Status: Completed

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma


Conditions: Mesothelioma

Last Updated: June 5, 2019

Status: Completed

E-MOSAIC Electronic Tool to Monitor Symptoms


Conditions:

Last Updated: May 14, 2019

Status: Completed

CART-meso in Mesothelin Expressing Cancers


Conditions: Mesothelioma

Last Updated: February 22, 2019

Status: Completed

Chest Wall Motion Analysis in Disease


Conditions: Mesothelioma

Last Updated: February 21, 2019

Status: Completed

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM


Conditions: Mesothelioma

Last Updated: January 14, 2019

Status: Completed

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 14, 2019

Status: Completed

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program


Conditions: Mesothelioma

Last Updated: January 10, 2019

Status: Completed

18F-FSPG PET/CT for Cancer Patients on Therapy


Conditions: Mesothelioma

Last Updated: December 11, 2018

Status: Completed

WT-1 Analog Peptide Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy


Conditions: Mesothelioma

Last Updated: November 1, 2018

Status: Completed

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma


Conditions: Mesothelioma

Last Updated: September 17, 2018

Status: Completed

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: July 11, 2018

Status: Completed

Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: June 12, 2018

Status: Completed

A Study in Non Small Cell Lung Cancer


Conditions:

Last Updated: May 16, 2018

Status: Completed

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy


Conditions: Mesothelioma

Last Updated: March 13, 2018

Status: Completed

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: December 30, 2017

Status: Completed

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma

Last Updated: December 27, 2017

Status: Completed

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors


Conditions: Mesothelioma

Last Updated: November 27, 2017

Status: Completed

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma


Conditions: Mesothelioma

Last Updated: November 3, 2017

Status: Completed

Autologous Redirected RNA Meso-CIR T Cells


Conditions: Mesothelioma

Last Updated: September 16, 2017

Status: Completed

Nivolumab in Patients With Recurrent Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: September 13, 2017

Status: Completed

Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)


Conditions: Mesothelioma

Last Updated: July 17, 2017

Status: Completed

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.


Conditions: Mesothelioma

Last Updated: July 6, 2017

Status: Completed

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.


Conditions: Mesothelioma

Last Updated: June 8, 2017

Status: Completed

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)


Conditions: Mesothelioma

Last Updated: April 24, 2017

Status: Completed

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 27, 2017

Status: Completed

Thrombin Generation and Platelet Activation in CRS/HIPEC


Conditions: Mesothelioma

Last Updated: January 24, 2017

Status: Completed

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: December 5, 2016

Status: Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases


Conditions:

Last Updated: November 16, 2016

Status: Completed

Collecting Tumor Samples From Patients With Gynecological Tumors


Conditions: Mesothelioma

Last Updated: October 26, 2016

Status: Completed

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers


Conditions: Mesothelioma

Last Updated: September 28, 2016

Status: Completed

Mesothelioma Avastin Plus Pemetrexed-cisplatin Study


Conditions: Mesothelioma

Last Updated: September 1, 2016

Status: Completed

Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays


Conditions: Mesothelioma

Last Updated: July 25, 2016

Status: Completed

Capecitabine in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: July 12, 2016

Status: Completed

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: July 11, 2016

Status: Completed

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: June 30, 2016

Status: Completed

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)


Conditions: Mesothelioma

Last Updated: May 29, 2016

Status: Completed

Tomotherapy Treatment for Mesothelioma


Conditions: Mesothelioma

Last Updated: April 5, 2016

Status: Completed

B-Receptor Signaling in Cardiomyopathy


Conditions: Mesothelioma

Last Updated: November 16, 2015

Status: Completed

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: November 16, 2015

Status: Completed

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 13, 2015

Status: Completed

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy


Conditions: Mesothelioma

Last Updated: October 19, 2015

Status: Completed

Intrapleural Gene Transfer for Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 21, 2015

Status: Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma


Conditions:

Last Updated: July 7, 2015

Status: Completed

Isolated Thoracic Perfusion (ITP-F) for MPM


Conditions: Mesothelioma

Last Updated: June 9, 2015

Status: Completed

Immunotoxin Therapy in Treating Patients With Advanced Cancer


Conditions: Mesothelioma

Last Updated: April 29, 2015

Status: Completed

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors


Conditions: Mesothelioma

Last Updated: April 29, 2015

Status: Completed

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 11, 2015

Status: Completed

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: January 28, 2015

Status: Completed

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: December 30, 2014

Status: Completed

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients


Conditions: Mesothelioma

Last Updated: December 1, 2014

Status: Completed

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery


Conditions: Mesothelioma

Last Updated: July 25, 2014

Status: Completed

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: May 5, 2014

Status: Completed

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite


Conditions: Mesothelioma

Last Updated: March 4, 2014

Status: Completed

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 26, 2014

Status: Completed

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 10, 2014

Status: Completed

Rapamycin With Grapefruit Juice for Advanced Malignancies


Conditions:

Last Updated: January 16, 2014

Status: Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain


Conditions:

Last Updated: January 14, 2014

Status: Completed

Serum Biomarkers in Diagnosis of Mesothelioma


Conditions: Mesothelioma

Last Updated: January 6, 2014

Status: Completed

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: August 6, 2013

Status: Completed

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors


Conditions: Mesothelioma

Last Updated: July 9, 2013

Status: Completed

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors


Conditions: Mesothelioma

Last Updated: July 9, 2013

Status: Completed

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors


Conditions: Mesothelioma

Last Updated: July 9, 2013

Status: Completed

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer


Conditions: Mesothelioma

Last Updated: July 9, 2013

Status: Completed

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer


Conditions: Mesothelioma

Last Updated: July 9, 2013

Status: Completed

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer


Conditions: Mesothelioma

Last Updated: July 9, 2013

Status: Completed

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: June 27, 2013

Status: Completed

Alanosine in Treating Patients With Cancer


Conditions: Mesothelioma

Last Updated: June 25, 2013

Status: Completed

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.


Conditions: Mesothelioma

Last Updated: June 4, 2013

Status: Completed

SU5416 in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: May 31, 2013

Status: Completed

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung


Conditions: Mesothelioma

Last Updated: January 23, 2013

Status: Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction


Conditions: Mesothelioma

Last Updated: January 15, 2013

Status: Completed

Gefitinib in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: January 15, 2013

Status: Completed

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 30, 2012

Status: Completed

Interleukin-12 in Treating Patients With Cancer in the Abdomen


Conditions:

Last Updated: July 27, 2012

Status: Completed

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura


Conditions: Mesothelioma

Last Updated: July 17, 2012

Status: Completed

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed


Conditions: Mesothelioma

Last Updated: July 17, 2012

Status: Completed

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: June 5, 2012

Status: Completed

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung


Conditions: Mesothelioma

Last Updated: May 14, 2012

Status: Completed

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs


Conditions: Mesothelioma

Last Updated: March 14, 2012

Status: Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma


Conditions:

Last Updated: March 14, 2012

Status: Completed

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma


Conditions: Mesothelioma

Last Updated: December 23, 2011

Status: Completed

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors


Conditions:

Last Updated: September 26, 2011

Status: Completed

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer


Conditions:

Last Updated: April 23, 2011

Status: Completed

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: March 25, 2011

Status: Completed

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma


Conditions: Mesothelioma

Last Updated: February 25, 2011

Status: Completed

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment


Conditions: Mesothelioma

Last Updated: November 17, 2010

Status: Completed

Dendritic Cell-based Immunotherapy in Mesothelioma


Conditions: Mesothelioma

Last Updated: November 15, 2010

Status: Completed

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen


Conditions: Mesothelioma

Last Updated: June 10, 2010

Status: Completed

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: September 17, 2009

Status: Completed

Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy


Conditions:

Last Updated: July 22, 2008

Status: Completed

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: November 5, 2007

Status: Completed

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma


Conditions: Mesothelioma

Last Updated: April 10, 2007

Status: Completed